Explore this issueFebruary/March 2014
Non-O157 verocytotoxin-producing E. coli (VTEC)/Shiga toxin-producing E. coli (STEC) are organisms of significant and growing public health concern because of their ability to cause extremely severe illness and their high potential for foodborne transmission. Increasing regulation in the U.S. and in Europe now requires rigorous testing at various stages of food production processes. It is therefore timely to examine the nature, characterization, and detection of these organisms. Especially noteworthy is the reemergence of immunomagnetic separation (IMS) as a technique of interest. IMS is now written into USDA methodology for the detection and isolation of non-O157 STEC in meat products, alongside real-time polymerase chain reaction (PCR)-based testing, and so we are seeing a renewed emphasis on its use.
Used interchangeably, the terms VTEC and STEC refer to pathogenic strains of the organism that can cause not only diarrhea but also more severe disease in humans, including haemorrhagic colitis and haemolytic uremic syndrome (HUS). These bacteria are of several different E. coli serogroups, a number of which are now firmly associated with the risk of serious illness in vulnerable individuals and populations.
The most commonly identified VTEC/STEC strain is E. coli O157:H7. Often referred to simply as O157, this organism has been recognized as a foodborne pathogen since the early 1980s. It follows that much of what is known about STEC comes from studies of E. coli O157 infection, but over the years other “non-O157” STEC serogroups have continued to emerge as important causes of disease.
The characteristics that are used to define STECs are their serotype, virulence factors, and biochemical profile. This latter relates to their phenotypic expression on diagnostic media and the biochemical similarities of many non-O157 STECs presents challenges when it comes to their isolation and identification.
Serotyping has a key role in the study of E. coli and follows a modified version of a scheme set out by Kauffmann in the 1940s. According to this scheme, E. coli are serotyped on the basis of their O (somatic), H (flagellar), and K (capsular) surface antigen profiles. The O antigen is the O-specific polysaccharride of the cell wall (LPS). A total of 178 different O antigens (O1 – O181), each defining a serogroup, are currently recognized and a further six have been demonstrated. A specific combination of O and H antigens defines the serotype of an isolate.
The main virulence genes for STEC are the Shiga toxin-encoding stx1 and stx2 genes, and the eae gene which encodes the intimin protein. Shiga toxin acts by shutting down cellular protein synthesis in target cells, including vascular epithelium where it can affect small blood vessels, such as those in the gastrointestinal tract and the kidneys, with potentially devastating consequences. The intimin protein is expressed on the bacterial cell surface and has a role in attaching to and effacing cell membranes.